Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I've been watching as well. Level II shows thin asks all the way up. Seems it wouldn't take much buying pressure to send it much higher.
As always, simply my opinion.
BIPH
We are once again ascending the most posted and most read boards. Ignition is now just a matter of time...
DSGT
Looks like DSGT might be about ready to move upward...
DSGT
She's about to explode upward...
LCLP
Agreed. RSI has been in a healthy uptrend, and daily candle chart is definitely showing price recovery strength.
DSGT
A quarter of a million dollars traded today and yesterday's price support held. I'd expect this to close in the mid 2's.
As always, simply my opinion.
DSTG
DSGT top 2 most read and most posted, top 10 most volume and a nicely consolidating uptrend chart. Should be a nice afternoon...
DSGT
COTE now at the top of the breakout boards...
COTE
level 2 definitely indicates thinner on the ask side than on the bid side...
BIPH
BIPH now moving up the iHub breakout board...
BIPH
gid·dy-up OWOO
''gide??p/
exclamation
used to get a horse to start moving or go faster.'
OWOO
It is called creating goodwill. The veteran community is a tight-knit group of people, and it is likely that word of this will spread amongst many of them.
Shareholder value will be enormous once sales have exceeded $200 million annually and (if/when) they are generating a sustainable profit. I do not think that we are too far off from that day.
As always, simply my opinion.
Regarding the potential $1 billion valuation for MSLP, here's something I posted here (in sept of 2013) - below in blue...
"Hypothesis: Muscle Pharm could be valued at $1 billion within the next 24 months. How can such a seemingly absurd statement be made? Because I found a number of NASDAQ and NYSE companies with quarterly revenue in the neighborhood of $10 - $35 million with a market cap of between $800 million and $1.1 billion.
Some examples that I've found are NASDAQ:HALO, NASDAQ:PFPT, NYSE:GIMO, NASDAQ:ELGX, NASDAQ:HSTM, NYSE:STAG, and NASDAQ:EPZM.
some key stats
HALO: (market cap of $1 billion; booking losses every quarter; accumulated deficit $340 million)
PFPT: (market cap of $1 billion; booking losses every quarter; accumulated deficit $190 million)
GIMO: (market cap of $1.1 billion; accumulated deficit $22 million)
ELGX: (market cap of $1 billion; only recently turned the corner into profitability; accumulated deficit of $200 million)
HSTM: (market cap of $950 million; accumulated deficit of $21 million)
STAG: (market cap $870 million; booking losses nearly every quarter; accumulated deficit of $90 million)
EPZM: (market cap $920 million; accumulated deficit of $62 million)
What most of these companies have in common with Muscle Pharm is the high rate of sales growth over the past few years, as well as their long history of net losses while growing sales. Some have reported profits in the more recently completed quarters. For those unfamiliar with the term 'accumulated deficit', it refers to the cumulative losses since inception. Companies with a solid track record of positive earnings would have a 'retained earnings' balance, rather than an 'accumulated deficit' balance.
I feel the above examples make it at least plausible that Muscle Pharm could achieve a market cap of $1 billion within the next 24 months. As always, simply my opinion."
link:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=92070131
The irony is not lost on me that you are talking about whether Muscle Pharm has enough money to dissolve, as they continue to build the next Nike.
You have provided many, many thought provoking questions here over the years, but as to the big picture now, I believe you are not seeing the forest for the trees.
As always, simply my opinion.
BTW, I do acknowledge that they are now and have for a while been expanding at a dangerous pace (extremely cash strapped), but some how they have managed to do it, rather effectively, on the razor's edge.
Touche...
While the point is certainly a relevant one:
-if Ford can succeed without Henry
-if Disney can succeed without Walt
-if Apple can succeed without S. Jobs
-and if Walmart can succeed without Sam
then I think that Muscle Pharm can succeed without a strong golf comeback story from Tiger...
The backlog delta must be factored in when computing the increase/decrease in demand. If the stated order backlog is legit, demand is closer to flat...
Glad I added thousands of shares in the $3's when it dropped from about $8...
At times, you are very insightful, The ExpertHimself. I don't think that JLTG could have stated that any better. The market will speak loudly (w/ a positive bias) by 10am on Tuesday.
As always, simply my opinion.
MSLP
Similar reports have been published (for decades) regarding artificial sweeteners and their linkage to cancer, but I use about 8-10 little pink packets in every one of my delicious dunkin' donuts rocky road iced coffees.
"What have studies shown about a possible association between specific artificial sweeteners and cancer?
Saccharin
Studies in laboratory rats during the early 1970s linked saccharin with the development of bladder cancer. For this reason, Congress mandated that further studies of saccharin be performed and required that all food containing saccharin bear the following warning label: “Use of this product may be hazardous to your health. This product contains saccharin, which has been determined to cause cancer in laboratory animals.”"
http://www.cancer.gov/cancertopics/causes-prevention/risk/diet/artificial-sweeteners-fact-sheet
That's a fair point, Codie. As an impulse buy, for immediate consumption, I would never buy a warm can of anything at a gas station.
On the other hand, if it was a beverage that I enjoyed drinking several times a day (such as a Monster beverage), I would probably buy a bunch of warm cans for consumption later (if the price was right).
I have to admit that the way the cases of MP Energy Sport were displayed, it did have an element of 'staged' to it.
On a side note, I would get frustrated (several years back) when you would provide your counterbalance to the discussion. I want to go on the record here as saying that I now appreciate your point of view. You bring a perspective which is vital to a balanced discussion.
As always, simply my opinion.
While no company sets out to lose money, the cumulative losses (such as the losses incurred by Muscle Pharm) do create an accounting asset known as a tax loss carry-forward. The main feature of such an asset is that it can serve to reduce the future income tax burden by about 30%. That is because future earnings can be offset by the losses which have already occurred, reducing the taxable earnings base.
I'm not sure what the total losses incurred have been, but they have been more than $70 million for just the past four years (CYs 2011-2014).
The presence of a large tax loss carry-forward alone is sometimes enough motivation for another entity to target the tax loss carry-forward holder as a takeover candidate.
Here's something that many people already understand about technical analysis and its predictive power. The moment that an unexpected huge downside surprise is reported/announced, like the disastrous 4th quarter than Muscle Pharm reported, the technical analysis (based off of historical data) is worthless.
IMO, Muscle Pharm will eventually be as dominant within the nutritional supplement world, as Apple is with consumer electronics.
As always, simply my opinion.
MSLP
It could be, if there was even a shred of evidence to support it. If you have any evidence that the scope of the MSLP SEC investigation is increasing (other than the long duration), please provide it here.
What I see as most relevant, are the following three words regarding MP... 'The Next Nike'. Let that resonate a bit, while you point out those obvious and critical missteps on that broken road, that led us straight to here (sung to the tune of Rascal Flatts 'Bless the Broken Road').
How you suppose the shares I referenced in the post below (on the day I added thousands of MSLP shares) are doing?
PanchoJimenz, you are correct. It seems some may have learned accounting bookings and treatment on a message board. I spent the requisite number of years being educated, and then had 6 of the big 8 accounting firms requesting to interview me. That's the last time I'll site my credentials here, as it is irrelevant to the discussion of MP's future prospects.
As always, simply my opinion.
Muscle Pharm was cash flow positive (from operations) for Q4, 2014. The way you can tell is that the red number for the 12 months ended 12/31/14 is smaller than the red number for the 9 months ended 9/30/14 (see below). And Muscle Pharm was approx cash flow neutral across the entire cash flow statement (operations, investing, and financing).
As always, simply my opinion.
The person who wrote today's Seeking Alpha article must be a bit challenged. Here are two points in their article:
-Positives: Q4 positive cash flow and free cash flow.
MusclePharm (OTCQB:MSLP) reported some ugly numbers for Q4.
-75% decrease in cash
I'd love to see the explanation for a scenario where a company accomplishes the two items above, when they are mutually exclusive. Either they got the fiscal periods confused, or they need a better calculator.
As always, simply my opinion.
MSLP
I did the same.
Don't be surprised it this begins to run on the Walmart retail shelf news...
OWOO
It took Sirius sat radio about 36 months to slide from about $8 down to about .05. The return trip to $4 took a bit more time (but was well worth the wait). IMO, MSLP will have its big run eventually.
So might MP... they are like the twinkie or spam of the supplement world...
"But in regard to the cash situation, I just don't see where the crisis is. As of December 13, 2014, current assets (Cash + Accounts Receivables + Inventory) amounted to about $39 million, whereas current liabilities (Accounts Payable + Accrued Liabilities) amounted to about $35 million. That means there is a working capital surplus as of Dec 31, 2014. If the lion's share of the inventory they are holding is not obsolete (without seeing a detailed breakdown to crosscheck against the hot selling products, there's no way for me to know), that inventory will be converted into cash and applied to the rather large payables figure."
link:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=111875249
Good point. So we should be able to have a higher degree of confidence that the positive working capital position presented for the tail end of Q4 is authentic.
What's important to keep in mind is that by the time we (outside shareholders) saw the numbers reflecting the cash position at the end of Q4, they were already deep into the next quarter (Q1) and had to have dealt with any of those potential cash issues in real time.
Because they had a positive working capital position at the end of Q4, I was not overly concerned with the relatively small cash balance. In other words, they had plenty of inventory and receivables ready to convert into cash to cover the trade payables and other cash obligations.
I understand your points, but eat-what-you-kill will always provide a stronger incentive (and closer shareholder alignment) than a lucrative starting point with an additional opportunity for upside.
BTW, I'm not too concerned with the accounting treatment of any of the compensation methods. I only want sr. mgmt to benefit when we (outside shareholders) benefit and have little to no equity rewards when shareholders are hurt.
As always, simply my opinion.